The Roles of Integrin α5β1 in Human Cancer

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2021 Jan 7

PMID 33408483

Citations 50

Authors

Jianbing Hou

Du Yan

Yudong Liu

Pan Huang

Hongjuan Cui

Affiliations

Soon will be listed here.

Abstract

Cell adhesion to the extracellular matrix has important roles in tissue integrity and human health. Integrins are heterodimeric cell surface receptors that are composed by two non-covalently linked alpha and beta subunits that mainly participate in the interaction of cell-cell adhesion and cell-extracellular matrix and regulate cell motility, adhesion, differentiation, migration, proliferation, etc. In mammals, there have been eighteen α subunits and 8 β subunits and so far 24 distinct types of αβ integrin heterodimers have been identified in humans. Integrin α5β1, also known as the fibronectin receptor, is a heterodimer with α5 and β1 subunits and has emerged as an essential mediator in many human carcinomas. Integrin α5β1 alteration is closely linked to the progression of several types of human cancers, including cell proliferation, angiogenesis, tumor metastasis, and cancerogenesis. In this review, we will introduce the functions of integrin α5β1 in cancer progression and also explore its regulatory mechanisms. Additionally, the potential clinical applications as a target for cancer imaging and therapy are discussed. Collectively, the information reviewed here may increase the understanding of integrin α5β1 as a potential therapeutic target for cancer.

Citing Articles

Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer.

Wani T, Kim H, Lee G, Lim Y, Chae H, Kim J Sci Rep. 2025; 15(1):3053.

PMID: 39856185 PMC: 11760351. DOI: 10.1038/s41598-025-87388-8.

Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells.

Maharati A, Rajabloo Y, Moghbeli M Heliyon. 2025; 11(1):e41483.

PMID: 39834411 PMC: 11743095. DOI: 10.1016/j.heliyon.2024.e41483.

Structural and functional characterization of integrin α5-targeting antibodies for anti-angiogenic therapy.

Nguyen A, Heim J, Cordara G, Chan M, Johannesen H, Charlesworth C bioRxiv. 2025; .

PMID: 39829743 PMC: 11741253. DOI: 10.1101/2025.01.08.631572.

Glioma-Derived Exosomes and Their Application as Drug Nanoparticles.

Mastantuono S, Manini I, Di Loreto C, Beltrami A, Vindigni M, Cesselli D Int J Mol Sci. 2024; 25(23).

PMID: 39684236 PMC: 11641060. DOI: 10.3390/ijms252312524.

Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer.

Qiao J, Guo D, Tian H, Wang Z, Fan Q, Tian Y Mater Today Bio. 2024; 29:101358.

PMID: 39677523 PMC: 11638641. DOI: 10.1016/j.mtbio.2024.101358.

References

Naci D, Vuori K, Aoudjit F . Alpha2beta1 integrin in cancer development and chemoresistance. Semin Cancer Biol. 2015; 35:145-53. DOI: 10.1016/j.semcancer.2015.08.004. View

Meng X, Jin Y, Yu Y, Bai J, Liu G, Zhu J . Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer. 2009; 101(2):327-34. PMC: 2720209. DOI: 10.1038/sj.bjc.6605154. View

Guo M, Sahni S, Sahni A, Francis C . Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells. Thromb Haemost. 2004; 92(4):858-66. DOI: 10.1160/TH04-04-0261. View

Roberts M, Woods A, Dale T, van der Sluijs P, Norman J . Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of alpha v beta 3 and alpha 5 beta 1 integrins. Mol Cell Biol. 2004; 24(4):1505-15. PMC: 344170. DOI: 10.1128/MCB.24.4.1505-1515.2004. View

Subbaram S, DiPersio C . Integrin α3β1 as a breast cancer target. Expert Opin Ther Targets. 2011; 15(10):1197-210. PMC: 3212412. DOI: 10.1517/14728222.2011.609557. View

Isaji T, Sato Y, Zhao Y, Miyoshi E, Wada Y, Taniguchi N . N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function. J Biol Chem. 2006; 281(44):33258-67. DOI: 10.1074/jbc.M607771200. View

Hwang J, Sung J, Kim J, Chung Y, Park J, Lee S . Caveolin-1-dependent and -independent uPAR signaling pathways contribute to ganglioside GT1b induced early apoptosis in A549 lung cancer cells. Am J Cancer Res. 2014; 4(6):801-10. PMC: 4266713. View

Tjong W, Lin H . The role of the RGD motif in CD97/ADGRE5-and EMR2/ADGRE2-modulated tumor angiogenesis. Biochem Biophys Res Commun. 2019; 520(2):243-249. DOI: 10.1016/j.bbrc.2019.09.113. View

Tang C, Keng Y, Liu J . HMGB-1 induces cell motility and α5β1 integrin expression in human chondrosarcoma cells. Cancer Lett. 2012; 322(1):98-106. DOI: 10.1016/j.canlet.2012.02.014. View

10.

Toquet C, Colson A, Jarry A, Bezieau S, Volteau C, Boisseau P . ADAM15 to α5β1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis. Int J Cancer. 2010; 130(2):278-87. DOI: 10.1002/ijc.25891. View

11.

McFarlane S, McFarlane C, Montgomery N, Hill A, Waugh D . CD44-mediated activation of α5β1-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and fibronectin-enriched matrices. Oncotarget. 2015; 6(34):36762-73. PMC: 4742209. DOI: 10.18632/oncotarget.5461. View

12.

Kapp T, Di Leva F, Notni J, Rader A, Fottner M, Reichart F . N-Methylation of isoDGR Peptides: Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging Agent. J Med Chem. 2018; 61(6):2490-2499. DOI: 10.1021/acs.jmedchem.7b01752. View

13.

Landreville S, Vigneault F, Bergeron M, Leclerc S, Gaudreault M, Morcos M . Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigment Cell Melanoma Res. 2011; 24(4):643-55. DOI: 10.1111/j.1755-148X.2011.00869.x. View

14.

Dia V, Gonzalez de Mejia E . Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling. Cancer Lett. 2011; 313(2):167-80. DOI: 10.1016/j.canlet.2011.09.002. View

15.

Lynch L, Vodyanik P, Boettiger D, Guvakova M . Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells. Mol Biol Cell. 2004; 16(1):51-63. PMC: 539151. DOI: 10.1091/mbc.e04-05-0399. View

16.

Damiano J, Hazlehurst L, Dalton W . Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 2001; 15(8):1232-9. DOI: 10.1038/sj.leu.2402179. View

17.

George E, Rayburn H, Hynes R . Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993; 119(4):1079-91. DOI: 10.1242/dev.119.4.1079. View

18.

Martinkova E, Maglott A, Leger D, Bonnet D, Stiborova M, Takeda K . alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells. Int J Cancer. 2010; 127(5):1240-8. DOI: 10.1002/ijc.25187. View

19.

Lahlou H, Muller W . β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Res. 2012; 13(6):229. PMC: 3326542. DOI: 10.1186/bcr2905. View

20.

Hang Q, Isaji T, Hou S, Wang Y, Fukuda T, Gu J . A Key Regulator of Cell Adhesion: Identification and Characterization of Important -Glycosylation Sites on Integrin α5 for Cell Migration. Mol Cell Biol. 2017; 37(9). PMC: 5394273. DOI: 10.1128/MCB.00558-16. View